Evelina Tacconelli
Statistics and Probability · 2010–2021
A researcher in the Science corpus: 8 papers; trusts 9 researchers and is trusted by 26 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 52 citations into it; #2,300 of 12,932 by trust here, #2,108 by citations
- General Health Professions — 36 citations into it; #334 of 4,781 by trust here, #727 by citations
- Economics and Econometrics — 20 citations into it
- Surgery — 20 citations into it
- Critical Care and Intensive Care Medicine — 7 citations into it
Whom Evelina Tacconelli trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Douglas G. Altman
- Julian P. T. Higgins
- J. Deeks
- Matthias Egger
- A. Sutton
- David Moher
- T. Russo
- John P. A. Ioannidis
- J. Sterne
- A. Briggs
Who trusts Evelina Tacconelli overall
- E. King
- I. Robertson
- D. Capaldi
- D. Hoy
- Cyrus Samii
- Cary L. Cooper
- N. Knoble
- Birte Snilstveit
- L. Manea
- P. Brooks
Papers from Evelina Tacconelli's perspective
Ordered by how strongly the researchers Evelina Tacconelli trusts endorse each paper. Same corpus, a different order for every researcher.
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (British medical journal)
- Controlling the risk of spurious findings from meta‐regression (Statistics in Medicine)
- Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. (Archives of Internal Medicine)
- Interventions to improve antibiotic prescribing practices for hospital inpatients. (Cochrane Database of Systematic Reviews)
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (Clinical Microbiology and Infection)
- Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study (British medical journal)
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and… (Infection control and hospital epidemiology)
- Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. (Journal of Infectious Diseases)
Their papers
- Systematic reviews: CRD's guidance for undertaking reviews in health care (2010) — 3,179 citations
- European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine). (2021) — 838 citations
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results (2020) — 2,324 citations
- Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions (2018) — 1,066 citations
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) — 4,785 citations
- Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. (2017) — 700 citations
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. (2014) — 800 citations
- Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. (2010) — 640 citations